[The effects of constituents of an antitussive and expectorant preparation on physical dependence on and antitussive activity of dihydrocodeine].
The effects of constituents of an antitussive and expectorant preparation on physical dependence potential and antitussive activity of dihydrocodeine (DC) were studied. Rats were treated with DC, methylephedrine (ME), chlorpheniramine (CP), and caffeine (CA) singly or simultaneously admixed with food (DC 0.125, ME: 0.25, CP: 0.05, CA: 0.25 mg /g of food) for 7 days. Subsequently, rats were treated with naloxone (0.5 mg/kg, sc) and withdrawal signs produced were observed. Naloxone-precipitated body weight loss in DC-treated rats was suppressed by simultaneous administration of the three drugs (ME, CP and CA) or CP, which is a H1-receptor antagonist. In abrupt withdrawal, the withdrawal signs were also suppressed by CP. Moreover, tripelennamine, the same kind of H1-receptor antagonist, suppressed naloxone-precipitated withdrawal signs, but cimetidine H2-receptor antagonist, did not suppress them. These results may suggest that H1-receptor antagonists suppress the development of physical dependence on DC, and that H1-receptors play an important role in the physical dependence. On the other hand, the cough reflex was induced by electric stimulation in order to evaluate the influence of ME, CP, and CA on antitussive effect of DC in guinea pigs. ME enhanced the effect of DC. These experimental findings suggest that the constituents of the antitussive and expectorant preparation suppress the development of physical dependence on DC, though they increase the antitussive effect of DC.
Yoshii
T
T
Department of Applied Pharmacology, School of Pharmacy, Hoshi University.
Masukawa
Y
Y
Fukagawa
Y
Y
Suzuki
T
T
Misawa
M
M
Yanaura
S
S
D000818:Animals; D000996:Antitussive Agents / Q000627:therapeutic use*; D003061:Codeine / Q000031:analogs & derivatives*; D003371:Cough / Q000188:drug therapy*; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D005100:Expectorants / Q000627:therapeutic use*; D006168:Guinea Pigs; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D019966:Substance-Related Disorders / Q000517:prevention & control*
D000996:Antitussive Agents; D005100:Expectorants; D006634:Histamine H1 Antagonists; C014481:dihydrocodeine; D003061:Codeine